智通财经APP获悉，今海医疗科技(02225)早盘涨超14%，截至发稿，涨13.94%，报1.88港元，成交额304.05万港元。
消息面上，今海医疗科技发布公告，拟向3名独立私人投资者各配售4000万股新股，合共1.2亿股新股，占扩大后股本约2.27%；每股配售价1.35港元，涉资1.62亿港元。公司表示，所得款项净额约为1.61亿港元，拟用于为潜在并购医疗保健相关项目及/或公司及投资医疗保健相关产业提供资金；研发开支；及一般营运资金。
值得注意的是，7月2日，今海医疗科技的全资附属公司上海今海医疗科技有限公司与宁波戴维医疗器械股份有限公司(300314.SZ)的全资附属公司宁波维尔凯迪医疗器械有限公司订立为期五年的合作框架协议。根据该协议，上海今海与戴维医疗集团将致力于在国际市场上开展内窥镜产品的联合合作，旨在打造在国际市场上具有竞争力的高端医疗器械解决方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.